Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Webcasts|March 23, 2026
Measure Your Furanocoumarins Like a Pro with the Agilent Pro iQ
Author(s)Agilent
Listen
0:00 / 0:00
Webinar Date/Time: Tue, May 19, 2026 1:00 PM EDT
Frustrated by furanocoumarins? Join us for this webinar and find out how to easily measure furanocoumarins like a pro!
Register Free:
Event Overview:
This event will present the Agilent Pro iQ with the Multimode Source workflow for furanocoumarins. We will highlight limits of detection (LOD) and limits of quantification (LOQ) for the 8 furanocoumarin markers specified in IFRA Amendment 52. This methodology workflow was developed for implementation in a QC environment. We will present ruggedness and robustness data along with linearity, LOD, and LOQ.
Key Learning Objectives:
- Understand the workflow for quantitation of furanocoumarins in citrus products to comply with EU regulations
- Discuss an overview of the Multimode Source with simultaneous APCI and ESI ionization
- Understand the basics of LC-MS
Who Should Attend:
- Anyone working with natural citrus products
- Scientists, lab technicians, lab managers
Speakers:
Sue D’Antonio
Application Engineer
Agilent Technologies
Sue D’Antonio is an applications chemist in the Liquid Phase Separations Group at Agilent Technologies. Her application support extends to HPLC, UHPLC, CE, and LC-MS single-quad and time of flight across a wide range of markets and customers. Before coming to Agilent, D’Antonio worked in the chemical industry as a QC and R&D chemist.
Bita Parvizian, PhD
Application Engineer
Agilent Technologies
Bita Parvizian, PhD, an application engineer in the LC team, has been supporting LC and LC single quad across a wide range of markets and customers. Prior to joining Agilent, Parvizian worked as a MS specialist in analytical and research development.
Register Free:
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.